Tumor-associated macrophages (TAMs) also suppress T-cell activation and promote angiogenesis, contributing to immunotherapy resistance by overexpressing PD-1/PD-L1, TGF-β, VEGF, EGF, and MMP [123,124]. The gene discussed is TGFB1; the disease is neoplasm.